Biohaven Pharmaceutical
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of late-stage product candidates targeting neurological diseases and rare disorders. Biohaven Pharmaceutical is headquartered in New Haven, Connecticut.
Last updated on
About Biohaven Pharmaceutical
Founded
2014Estimated Revenue
$250M-$500MEmployees
251-1KFunding / Mkt. Cap
$1BCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
2834NAICs Code
541Location
City
New HavenState
ConnecticutCountry
United StatesTech Stack (35)
